Literature DB >> 20152744

Bariatric surgery for diabetes treatment: why should we go rapidly to surgery.

M Laville1, E Disse.   

Abstract

Surgical treatment of morbid obesity has been shown to be efficient for long-term weight loss and to improve obesity-related complications. The improvement of type 2 diabetes (T2DM) is dependent of the type of surgery, and is more frequent with gastric bypass than with gastric band. Normalization of glucose metabolism is rapid, often occurring before weight loss, and shown to be related to both a decrease in insulin resistance and an increase in insulin secretion. Some factors limiting the efficiency of gastric bypass on T2DM is the duration of diabetes and the residual beta-cell mass. However, a decrease in diabetes-related death has been found in a large series of surgical cases. These data constitute a good argument for proposing surgery in T2DM obese patients as soon as possible. Nevertheless, whether or not this suggests changing the usual indications for bariatric surgery in T2DM patients, such as a body mass index (BMI) score of<35 kg/m(2), remains controversial. Copyright 2009 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20152744     DOI: 10.1016/S1262-3636(09)73466-4

Source DB:  PubMed          Journal:  Diabetes Metab        ISSN: 1262-3636            Impact factor:   6.041


  9 in total

1.  First-phase insulin secretion, insulin sensitivity, ghrelin, GLP-1, and PYY changes 72 h after sleeve gastrectomy in obese diabetic patients: the gastric hypothesis.

Authors:  N Basso; D Capoccia; M Rizzello; F Abbatini; P Mariani; C Maglio; F Coccia; G Borgonuovo; M L De Luca; R Asprino; G Alessandri; G Casella; F Leonetti
Journal:  Surg Endosc       Date:  2011-06-03       Impact factor: 4.584

2.  Wide topical negative pressure wound dressing treatment for patients undergoing abdominal dermolipectomy following massive weight loss.

Authors:  Adrian Dragu; Stefan Schnürer; Frank Unglaub; Maya B Wolf; Justus P Beier; Ulrich Kneser; Raymund E Horch
Journal:  Obes Surg       Date:  2011-11       Impact factor: 4.129

3.  Effect of Resected Gastric Volume on Ghrelin and GLP-1 Plasma Levels: a Prospective Study.

Authors:  Federico Sista; Valentina Abruzzese; Marco Clementi; Sergio Carandina; Gianfranco Amicucci
Journal:  J Gastrointest Surg       Date:  2016-10-13       Impact factor: 3.452

4.  Laparoscopic gastric bypass for the adolescent patient: long-term results.

Authors:  S Nijhawan; Tracy Martinez; Alan C Wittgrove
Journal:  Obes Surg       Date:  2012-09       Impact factor: 4.129

5.  Predictive factors of type 2 diabetes remission 1 year after bariatric surgery: impact of surgical techniques.

Authors:  M Robert; C Ferrand-Gaillard; E Disse; P Espalieu; C Simon; M Laville; C Gouillat; C Thivolet
Journal:  Obes Surg       Date:  2013-06       Impact factor: 4.129

Review 6.  Obesity and appetite control.

Authors:  Keisuke Suzuki; Channa N Jayasena; Stephen R Bloom
Journal:  Exp Diabetes Res       Date:  2012-08-01

7.  Treatment of type 1 and type 2 diabetes mellitus with insulin detemir, a long-acting insulin analog.

Authors:  Jason R Young; Carrie McAdam-Marx
Journal:  Clin Med Insights Endocrinol Diabetes       Date:  2010-12-05

8.  Effects of bilio-pancreatic diversion on diabetic complications: a 10-year follow-up.

Authors:  Amerigo Iaconelli; Simona Panunzi; Andrea De Gaetano; Melania Manco; Caterina Guidone; Laura Leccesi; Donatella Gniuli; Giuseppe Nanni; Marco Castagneto; Giovanni Ghirlanda; Geltrude Mingrone
Journal:  Diabetes Care       Date:  2011-01-31       Impact factor: 19.112

9.  The gut hormones in appetite regulation.

Authors:  Keisuke Suzuki; Channa N Jayasena; Stephen R Bloom
Journal:  J Obes       Date:  2011-09-22
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.